NCT06044610View on ClinicalTrials.gov

Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Dehydration
Interventions
OTHER

GENPOP Passive dehydration (75% reduction in fluid intake

Over 24-hours

OTHER

GENPOP Ad lib fluid intake

Over 24 hours

OTHER

EXERCISE without fluid replacement

90-min standard cycling exercise trial in heat chamber

OTHER

EXERCISE with fluid replacement

90-min standard cycling exercise trial in heat chamber

Trial Locations (2)

10595

PepsiCo R&D, Gatorade Sports Science Institute, Valhalla

75024

PepsiCo R&D, Gatorade Sports Science Institute, Plano

All Listed Sponsors
lead

PepsiCo Global R&D

INDUSTRY

NCT06044610 - Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development | Biotech Hunter | Biotech Hunter